Robuta

Zepbound (tirzepatide) is a prescription injectable GLP-1 medication approved by the FDA for weight loss and management. See if you qualify for Zepbound!

Nov 25, 2025 - Most people who stopped taking their weight loss injections also experienced negative changes in blood pressure, waist size, and other health metrics.

Feb 19, 2026 - With insurance plans dropping coverage of the drugs, those of us benefiting from them face a costly decision — beyond just the monetary.

Nov 14, 2025 - GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of...

Nov 7, 2025 - Zepbound (tirzepatide) is a prescription injection for weight loss and weight management in adults. Learn about dosage, side effects, uses, and more.

Sep 11, 2025 - What insurance covers Zepbound: 1. Blue Cross Blue Shield, 2. UnitedHealthCare, 3. Aetna, 4. Cigna, 5. Humana, 6. Kaiser Permanente...

Nov 7, 2025 - A poll done in 2024 showed that roughly 12% of adults have taken a GLP-1 agonist, a type of drug used for weight loss, diabetes, and other health Wondering...

Sep 5, 2024 - Novo Nordisk and Eli Lilly, makers of blockbuster GLP-1 drugs, test amylin hormone receptor treatments in pursuit of fewer side effects.

Nov 17, 2023 - STAT Obesity Drug Tracker update: Companies turn to developing weight loss drugs that conserve muscle even as they erode fat.

Jan 8, 2026 - Data show that a combination treatment, including the therapy Taltz, was more effective than older therapy alone.

Aug 21, 2025 - Shopping for Zepbound online? We compared top platforms for cost, additional support, and convenience so you don’t have to.

Mar 25, 2025 - Zepbound, het broertje van het anderhalf eerder voor de verkoop goedgekeurde Mounjaro, is een nieuw medicijn voor problematisch overgewicht. Beiden bevatten...

Dec 2, 2025 - Eli Lilly slashes Zepbound to £227 ($299) monthly for US cash payers, but just £31 ($41) in India – though £241 ($319) in Japan.

Dec 17, 2025 - Discover why Zepbound stands apart in weight loss treatment. Learn how its dual GIP/GLP-1 mechanism works, boosts results, and differs from other medications.

Dec 18, 2025 - Need to know whether you can get Zepbound coverage through your Medicare plan? We’ll explain who’s covered and which plan you need.

Jul 15, 2025 - Zepbound is the first FDA-approved prescription drug for obstructive sleep apnea. Learn how it works, who can take it, and more. Wondering about Zepbound for...

In the third quarter of 2025, the revenue of Zepbound amounted to over 3.5 billion U.S.

Oct 30, 2025 - Consumers will soon be able to pick up single-dose vials of the weight loss drug Zepbound at Walmart pharmacies.

Jan 10, 2025 - Eli Lilly announced the FDA has approved Zepbound (tirzepatide) as the first and only prescription medication for adults with sleep apnea.

Oct 3, 2025 - Study reveals how therapeutic carb reduction and strength training help maintain or boost weight loss after stopping GLP-1 meds like Zepbound.

Mar 5, 2025 - Whether you’re a fan of the drug name Zepbound or, like one X user, think it sounds like “an off brand bus line,” you’re likely to have some opinion...

Nov 4, 2025 - GLP-1–based medicines now dominate diabetes and medical weight-loss headlines—but they’re not all the same. Some are approved for type 2 diabetes only,...

Dec 18, 2025 - Eli Lilly also said it has filed for Food and Drug Administration approval of the daily GLP-1 pill, called orforglipron, for obesity.

Feb 19, 2026 - The results of 2 recent clinical trials combining the GLP-1 drug and the biologic reinforce the benefits of treating obesity and inflammation together.

Zepbound includes dosage options at decreased prices, which might help people access it. However, high costs limit access for many without insurance.

"Explore Zepbound's potential side effects on gallbladder health, risks, and what you need to know for safe use."

Aug 22, 2025 - Learn how to travel with Zepbound, including temperature control, packing and storing the drug, TSA requirements, and international considerations.

Oct 29, 2025 - LillyDirect now accounts for 35% of new Zepbound prescriptions, with growth driven by self-pay pricing for tirzepatide launched in August 2024, says Lilly SVP...